Henry Schein announced that it received an expected notice on November 13, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market LLC advising the company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) because its quarterly report on Form 10-Q for the quarter ended September 30, 2023 would not be filed in a timely manner. The notice and the company’s response are mandated by Nasdaq and Securities and Exchange Commission rules.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HSIC:
- JPMorgan medical distribution analyst holds an analyst/industry conference call
- Henry Schein price target lowered to $82 from $90 at Barrington
- Henry Schein price target lowered to $78 from $84 at Piper Sandler
- Henry Schein price target lowered to $76 from $82 at Baird
- Henry Schein says could see 2024 dental growth towards lower end of 2%-4% range
